Can You Have a Healthy Pregnancy with Wilson Disease?
At a Glance
Women with Wilson disease can have healthy pregnancies, but they must never stop their anti-copper medication. Standard prenatal vitamins must be avoided because they contain copper. Close monitoring by a hepatologist and a high-risk obstetrician ensures both mother and baby stay safe.
In this answer
5 sections
Yes, women with Wilson disease can absolutely have healthy pregnancies and give birth to healthy babies [1][2]. The most important factor in a successful pregnancy is continuing your Wilson disease treatment [2]. With careful monitoring and expert guidance, most women can carry safely to term without their Wilson disease symptoms getting worse [3].
Why You Must Continue Your Medication
When planning a pregnancy, many women instinctively want to stop taking all medications to protect their baby. However, with Wilson disease, stopping your anti-copper medication is highly dangerous [3].
Discontinuing treatment can lead to a rapid buildup of toxic copper levels, which can cause severe liver failure or permanent neurological damage [3]. This not only threatens your life, but it also places your developing baby in extreme danger [3]. Your doctor will keep you on treatment throughout your entire pregnancy to protect both you and your baby [4]. You must also strictly maintain your low-copper diet during this time [5].
Prenatal Vitamins: A Critical Warning
Do not take standard prenatal vitamins without checking the label first. Most over-the-counter prenatal vitamins contain copper, which directly works against your medical treatment and is dangerous for anyone with Wilson disease [6][7].
You must ask your doctor to recommend a completely copper-free prenatal vitamin or take individual prescribed supplements (such as folic acid and iron) instead [7].
How Medications Are Adjusted During Pregnancy
While you will stay on your medication, your medical team—which should include both a hepatologist (liver specialist) and a maternal-fetal medicine specialist (high-risk obstetrician)—will carefully manage your dosage [1]. The goal is to keep your non-ceruloplasmin bound (free) copper levels in a safe range that protects your liver but allows the fetus to get the small amount of copper it needs to grow [8].
Chelators (D-penicillamine or Trientine):
If you take a chelator, your doctor will likely keep your dosage steady during the first and second trimesters [4]. However, as you enter the third trimester, your doctor will often reduce the dosage by 25% to 50% [4]. This reduction has two main purposes:
- It minimizes the very rare risk of connective tissue disorders in the baby [9][4].
- It ensures your body can properly heal wounds during and after delivery [4].
If you need a C-section or experience tearing during birth, maintaining lower chelator doses helps your tissues repair themselves normally. Once your wounds have healed after delivery, your doctor will return your dose to your normal, pre-pregnancy levels [10].
Zinc Therapy:
If you manage your Wilson disease with zinc salts, your doctor will generally keep you on your standard maintenance dose throughout the entire pregnancy [11]. Zinc works by blocking copper absorption in the gut rather than pulling it from tissues, and it is generally considered safe during pregnancy when properly monitored [11].
Monitoring and Multidisciplinary Care
Even with proper treatment, women with Wilson disease have a slightly higher risk of miscarriage (spontaneous abortion) and low birth weight compared to women without the condition [12]. This is why close, multidisciplinary monitoring is essential [1].
Expect to have medical appointments at least once a month. Your care team will monitor you closely using blood draws (to check liver function and free copper) and 24-hour urine collections (to ensure your copper levels aren’t getting too high or too low) [10][13].
Additionally, because Wilson disease is a genetic condition, your doctor will likely recommend genetic testing for your partner before you conceive or early in the first trimester [14]. If your partner does not carry a mutation in the ATP7B gene, your baby will be a carrier but will not develop Wilson disease [14][15].
Breastfeeding with Wilson Disease
Whether you can safely breastfeed depends heavily on your specific medication.
- Zinc: Breastfeeding while taking zinc is widely considered safe, as minimal amounts transfer into the breast milk [16][11].
- Chelators: If you are taking D-penicillamine or trientine, breastfeeding is generally discouraged [17]. These drugs can pass into breast milk and potentially harm the infant.
Your care team will help you weigh the risks and benefits, and may discuss switching you to zinc postpartum if appropriate for your liver health [17].
Common questions in this guide
Can I stop my Wilson disease medication when I get pregnant?
Are regular prenatal vitamins safe if I have Wilson disease?
Will my Wilson disease medication dose change during pregnancy?
Can I safely breastfeed my baby if I have Wilson disease?
Will my baby inherit Wilson disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Could you prescribe or recommend a specific copper-free prenatal vitamin for me?
- 2.Who will be coordinating my monthly blood and 24-hour urine tests between your office and my OB/GYN?
- 3.Should we plan to reduce my chelator dose in the third trimester, and exactly when will it be increased again after delivery?
- 4.Based on my current liver health, would it be safe to switch to zinc after delivery so that I can breastfeed?
- 5.Do you recommend my partner undergo ATP7B genetic testing, and can you refer us to a genetic counselor?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Wilson disease in pregnancy: A case series.
Xiong X, Wei H, Zhu Y, et al.
Medicine 2023; (102(7)):e32968 doi:10.1097/MD.0000000000032968.
PMID: 36800617 - 2
The Maternal and Fetal Outcomes of Pregnancy in Wilson's Disease: A Systematic Literature Review and Meta-Analysis.
Litwin T, Bembenek J, Antos A, et al.
Biomedicines 2022; (10(9)) doi:10.3390/biomedicines10092072.
PMID: 36140172 - 3
Pregnancy and Wilson disease: management and outcome of mother and newborns-experiences of a perinatal centre.
Reuner U, Dinger J
Annals of translational medicine 2019; (7(Suppl 2)):S56 doi:10.21037/atm.2019.04.40.
PMID: 31179293 - 4
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K, Beck E, Schaefer C
Reproductive toxicology (Elmsford, N.Y.) 2016; (65()):39-45 doi:10.1016/j.reprotox.2016.06.015.
PMID: 27350316 - 5
[Wilson's disease or hepatolenticular degeneration].
Mensing B, Nowak A, Zweifel S, et al.
Therapeutische Umschau. Revue therapeutique 2018; (75(4)):241-248 doi:10.1024/0040-5930/a000995.
PMID: 30468117 - 6
Wilson disease.
Członkowska A, Litwin T, Dusek P, et al.
Nature reviews. Disease primers 2018; (4(1)):21 doi:10.1038/s41572-018-0018-3.
PMID: 30190489 - 7
Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.
Teschke R, Eickhoff A
International journal of molecular sciences 2024; (25(9)) doi:10.3390/ijms25094753.
PMID: 38731973 - 8
Therapeutic strategies in Wilson disease: pathophysiology and mode of action.
Stremmel W, Weiskirchen R
Annals of translational medicine 2021; (9(8)):732 doi:10.21037/atm-20-3090.
PMID: 33987430 - 9
Penicillamine-Induced Localised Cutis Laxa in a Patient with Wilson Disease: A Case Report.
Routsi E, Kanelleas A, Papaefthymiou V, et al.
Mediterranean journal of rheumatology 2024; (35(1)):184-186 doi:10.31138/mjr.280223.pil.
PMID: 38736957 - 10
Pregnancy in Wilson's disease: Management and outcome.
Pfeiffenberger J, Beinhardt S, Gotthardt DN, et al.
Hepatology (Baltimore, Md.) 2018; (67(4)):1261-1269 doi:10.1002/hep.29490.
PMID: 28859232 - 11
Practical insights into chronic management of hepatic Wilson's disease.
Lynch EN, Campani C, Innocenti T, et al.
World journal of clinical cases 2022; (10(14)):4334-4347 doi:10.12998/wjcc.v10.i14.4334.
PMID: 35663095 - 12
Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy - A bicentric matched-control cohort study.
Roseira J, Lopes R, Silva MJ, et al.
Revista espanola de enfermedades digestivas 2022; (114(4)):198-203 doi:10.17235/reed.2020.7444/2020.
PMID: 33393331 - 13
Pearls & Oy-sters: Challenges and Controversies in Wilson Disease.
Ruiz-Lopez M, Moreno Estébanez A, Tijero B, et al.
Neurology 2022; (99(6)):251-255 doi:10.1212/WNL.0000000000200836.
PMID: 35940888 - 14
Genetic variation spectrum in ATP7B gene identified in Latvian patients with Wilson disease.
Zarina A, Tolmane I, Kreile M, et al.
Molecular genetics & genomic medicine 2017; (5(4)):405-409 doi:10.1002/mgg3.297.
PMID: 28717664 - 15
Molecular genetic diagnosis of Wilson disease by ARMS-PCR in a Pakistani family.
Khan HN, Wasim M, Ayesha H, Awan FR
Molecular biology reports 2018; (45(6)):2585-2591 doi:10.1007/s11033-018-4426-y.
PMID: 30426382 - 16
Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson's disease: a prospective study.
Kodama H, Anan Y, Izumi Y, et al.
BMJ paediatrics open 2021; (5(1)):e000948 doi:10.1136/bmjpo-2020-000948.
PMID: 34222678 - 17
Policy Statement: Breastfeeding and the Use of Human Milk.
Meek JY, Noble L,
Pediatrics 2022; (150(1)) doi:10.1542/peds.2022-057988.
PMID: 35921640
This page is for informational purposes only and does not replace professional medical advice. Always consult your hepatologist and maternal-fetal medicine specialist regarding pregnancy planning and Wilson disease management.
Get notified when new evidence is published on Wilson disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.